Document:

exv10w9

Exhibit 10.9

EMPLOYMENT AGREEMENT

          THIS AGREEMENT (this “Agreement”) is made as of April 28, 2001, by and between Research
Pharmaceutical Search, Inc., a Pennsylvania corporation d/b/a Research Pharmaceutical Services,
Inc. (the “Company”), and Janet Brennan (“Employee”). Any capitalized terms used herein and
otherwise not defined shall have the meanings assigned to them in Section 11 hereof.

          In consideration of the mutual covenants contained herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto,
intending to be legally bound hereby, agree as follows:

          1. Employment. The Company shall employ Employee, and Employee hereby accepts
employment with the Company, upon the terms and conditions set forth in this Agreement for the
period beginning on the date hereof and ending as provided in Section 4 hereof (the “Term”).

          2. Position and Duties.

               (a) Employee shall serve as the Vice President of Clinical Operations and Strategic
Development of the Company and shall have the normal duties, responsibilities and authority of the
Vice President of Clinical Operations and Strategic Development, subject to the overall discretion
and authority of the Board.

               (b) Employee shall report to the President of the Company, and Employee shall devote his or
her best efforts and his or her full business time and attention (except for permitted vacation
periods and reasonable periods of illness or other incapacity) to the business and affairs of the
Company and its Subsidiaries. Employee shall perform his or her duties and responsibilities to the
best of his or her abilities in a diligent, trustworthy, businesslike and efficient manner.

          3. Base Salary and Benefits.

               (a) During the Term, Employee shall be entitled to (i) receive a base salary of $165,000 per
annum or such other higher rate as the Board may designate from time to time (the “Base Salary”),
which shall be payable in regular installments in accordance with the Company’s general payroll
practices and shall be subject to customary withholding and (ii) participate in all benefit plans,
including medical, dental, retirement, short- and long-term disability, stock incentive and other
such plans established by the Company from time to time for executives or employees of the Company
generally (“Benefits”). In addition, Employee shall be eligible to receive an annual performance
bonus in such amount as determined by the Board in its sole discretion.

               (b) The Company shall reimburse Employee for all reasonable expenses incurred by him or her in
the course of performing his or her duties under this Agreement which are consistent with the
Company’s policies in effect from time to time with respect to travel, entertainment and other
business expenses, subject to the Company’s requirements with respect to reporting and
documentation of such expenses.

 

 

          4. Term.

               (a) The Term shall end one (1) year from the date hereof, except that the Term shall be
automatically renewed for successive one (1) year periods after the initial Term unless terminated
in writing by either the Company or Employee at least thirty (30) days prior to the end of the Term
or any renewal thereof; provided that (i) the Term and Employee’s employment shall
terminate prior to such date upon Employee’s death or permanent Disability and (ii) the Employee’s
employment may be terminated by the Company or the Employee at any time prior to such date.

               (b) The Employee’s employment may be terminated by the Company at any time for any reason. If
Employee’s employment is terminated by the Company without Cause during the Term of this Agreement,
Employee shall be entitled Base Salary and Benefits for a period of one (1) year following the date
of termination. Any such amounts payable under this Section 4(b) will be payable at such times as
such amounts would have been payable had Employee not been terminated. Notwithstanding anything in
this Agreement to the contrary, the Company shall have no obligation to pay any amounts payable
under this Section 4(b) during such times as Employee is in breach of Sections 5, 6, 7 or 8 hereof.
Upon request from time to time, Employee shall furnish the Company with a true and complete
certificate specifying any such compensation due to or received by him or her. As a condition to
the Company’s obligations (if any) to make severance payments pursuant to this Section 4(b),
Employee will execute and deliver a general release in form and substance reasonably satisfactory
to the Company.

               (c) If this Agreement is terminated pursuant to Section 4(a)(i) above, Employee shall be
entitled to receive his or her Base Salary through the date of termination. Any such amounts
payable under this Section 4(c) will be payable at such times as such amounts would have been
payable had Employee not been terminated.

               (d) If this Agreement is terminated by the Company for Cause or by the Employee, Employee
shall be entitled to receive his or her Base Salary through the date of termination. Any such
amounts payable under this Section 4(d) will be payable at such times as such amounts would have
been payable had Employee not been terminated.

               (e) During the period that Employee is entitled to payment of his or her Base Salary or other
payments under Section 4(b), the Company shall pay and maintain for Employee’s benefit Employee’s
participation and/or rights under the Company’s health, life and disability insurance plans, as
well as any other benefits then in effect. The Company may offset any amounts Employee owes it or
its Subsidiaries for liquidated claims against any amounts it owes Employee hereunder.

          5. Confidential Information. Employee acknowledges that the information, observations
and data obtained by him or her while employed by the Company and its Subsidiaries concerning the
business or affairs of the Company or any Subsidiary (“Confidential Information”) are the property
of the Company or such Subsidiary. Therefore, Employee agrees that he or she shall not disclose to
any unauthorized person or use for his or her own purposes any Confidential Information without the
prior written consent of the Board, unless and to the

-2-

 

extent that the aforementioned matters become generally known to and available for use by the
public other than as a result of Employee’s acts or omissions. Employee shall deliver to the
Company at the termination of his or her employment, or at any other time the Company may request,
all memoranda, notes, plans, records, reports, computer tapes, printouts and software and other
documents and data (and copies thereof) relating to the Confidential Information, Work Product (as
defined below) or the business of the Company or any Subsidiary which he or she may then possess or
have under his or her control.

          6. Inventions and Patents. Employee acknowledges that all inventions, innovations,
improvements, developments, methods, designs, analyses, drawings, reports and all similar or
related information (whether or not patentable) which relate to the Company’s or any of its
Subsidiaries’ actual or anticipated business, research and development or existing or future
products or services and which are conceived, developed or made by Employee while employed by the
Company and its Subsidiaries (“Work Product’) belong to the Company or such Subsidiary. Employee
shall promptly disclose such Work Product to the Board and perform all actions reasonably requested
by the Board (whether during or after Employee’s employment with the Company) to establish and
confirm such ownership (including, without limitation, assignments, consents, powers of attorney
and other instruments).

          7. Non-Compete. In further consideration of the compensation to be paid to Employee
hereunder, Employee acknowledges that in the course of his or her employment with the Company he or
she shall become familiar, and during his or her employment with the Company he or she has become
familiar, with the Company’s and its Subsidiaries’ trade secrets and with other Confidential
Information concerning the Company and its Subsidiaries and that his or her services have been and
shall be of special, unique and extraordinary value to the Company and its Subsidiaries.
Therefore, Employee agrees that, during the one (1) period following Employee’s termination of
employment (the “Non-Compete Period”), he or she shall not directly or indirectly own any interest
in, manage, control, participate in, consult with, render services for, or in any manner engage in
any business which is involved (or has definite plans to get involved) in business activities that
engage in the business of contract research organization, recruiting, staffing and placement of
personnel in the areas of clinical research, medical writing, biostatistics and programming.
Nothing herein shall prohibit Employee from being a passive owner of not more than 3% of the
outstanding stock of any class of a corporation which is publicly traded, so long as Employee has
no active participation in the business of such corporation.

          8. Non-Solicitation. During the one (1) year period immediately following the
termination of Employee’s employment (the “Non-Solicitation Period”), Employee shall not directly
or indirectly through another entity (i) induce or attempt to induce any employee of the Company or
any Subsidiary to leave the employ of the Company or such Subsidiary, or in any way interfere with
the relationship between the Company or any Subsidiary and any employee thereof, (ii) hire any
person, who was an employee of the Company or any Subsidiary at any time during the four (4) years
immediately preceding the Employee’s termination, (iii) induce or attempt to induce any customer,
supplier, licensee, licensor, franchisee or other business relation of the Company or any
Subsidiary to cease doing business with the Company or such Subsidiary, or in any way interfere
with the relationship between any such customer, supplier, licensee or business relation and the
Company or any Subsidiary (including, without limitation, making any

-3-

 

negative statements or communications about the Company or its Subsidiaries) or (iv) service
(except in the capacity of an employee) any customer, licensee, agent or franchisee of the Company
or any Subsidiary who was a customer, licensee, agent or franchisee of the Company or any
Subsidiary at any time during the two (2) years immediately preceding the Employee’s termination.

          9. Enforcement. If, at the time of enforcement of Sections 5, 6, 7 or 8 of this
Agreement, a court holds that the restrictions stated herein are unreasonable under circumstances
then existing, the parties hereto agree that the maximum period, scope or geographical area
reasonable under such circumstances shall be substituted for the stated period, scope or area. The
parties hereto agree that money damages would not be an adequate remedy for any breach of this
Agreement because the services provided by Employee pursuant to this Agreement are unique and
because Employee has access to Confidential Information and Work Product. As such, in the event a
breach or threatened breach of this Agreement, the Company or its successors or assigns may, in
addition to other rights and remedies existing in their favor, apply to any court of competent
jurisdiction for specific performance and/or injunctive or other relief in order to enforce, or
prevent any violations of, the provisions hereof (without posting a bond or other security). In
addition, in the event of an actual breach or violation by Employee of Sections 7 or 8, the
Non-Compete Period and the Non-Solicitation Period shall be tolled until such breach or violation
has been duly cured. Employee hereby acknowledges and agrees that the restrictions contained in
Sections 7 or 8 are reasonable.

          10. Employee’s Representations. Employee hereby represents and warrants to the
Company that (i) the execution, delivery and performance of this Agreement by Employee do not and
shall not conflict with, breach, violate or cause a default under any contract, agreement,
instrument, order, judgment or decree to which Employee is a party or by which he or she is bound,
(ii) Employee is not a party to or bound by any employment agreement, non-compete agreement or
confidentiality agreement with any other person or entity except as disclosed to the Company by
Employee in writing (including a copy of such agreement), and (iii) upon the execution and delivery
of this Agreement by the Company, this Agreement shall be the valid and binding obligation of
Employee, enforceable in accordance with its terms.

          11. Definitions.

          “Board” shall mean the board of directors of the Company.

          “Cause” shall mean (i) the conviction of a felony or the commission of any other act or
omission involving dishonesty or fraud, (ii) failure to perform duties as directed by the Board
(which failure is not cured within 30 days following written notice from the Board); provided such
duties are reasonable and consistent with the duties generally performed by an executive of the
same, title, stature, duties and position as Employee or are otherwise consistent with this
Agreement, (iii) gross negligence or willful misconduct with respect to the Company or any of its
Subsidiaries, or (iv) any material breach (which failure is not cured within 30 days following
written notice from the Board) of this Agreement.

          “Disability” (i) shall mean any physical or mental incapacitation which results in Employee’s
inability to perform his or her duties and responsibilities for the Company for a total

-4-

 

of 120 days during any twelve-month period, as determined by an Independent Medical Doctor and
(ii) shall be deemed to have occurred on the later of either the 120th day of such inability to
perform or the date on which the benefits under the Company’s long term disability insurance become
payable to the Employee. For the purposes of this definition, an “Independent Medical Doctor”
shall be a medical doctor chosen in the following manner: the Employee and the Board shall each
choose a medical doctor and such medical doctors, together, shall choose a third medical doctor who
shall be the Independent Medical Doctor.

          “Subsidiaries” shall mean any entity of which the securities having a majority of the voting
power in electing directors are, at the time of determination, owned by the Company, directly or
through one or more Subsidiaries.

          12. Survival. Sections 4, 5, 6, 7 and 8 and Sections 11 through 20 shall survive and
continue in full force in accordance with their terms notwithstanding any termination of the
Employee’s employment by the Company.

          13. Notices. Any notice provided for in this Agreement shall be in writing and shall
be either personally delivered, or mailed by overnight courier (by a reputable courier service) or
first class mail, return receipt requested, to the recipient at the address below indicated:

Notices to Employee:

Janet Brennan

c/o ReSearch Pharmaceutical Services, Inc.

725 Skippack Pike, Suite 200

Blue Bell, Pennsylvania 19422

Fax: (215) 540-0770

Notices to the Company:

ReSearch Pharmaceutical Services, Inc.

725 Skippack Pike, Suite 200

Blue Bell, Pennsylvania 19422

Fax: (215) 540-0770

Attention: President

with copies to:

Pepper Hamilton LLP

1235 Westlakes Drive Suite 400

Berwyn, PA 19312-2401\

Attention: James D. Rosener, Esq.

Telecopy: (610) 640-7835

-5-

 

or such other address or to the attention of such other person as the recipient party shall have
specified by prior written notice to the sending party. Any notice under this Agreement shall be
deemed to have been given when so delivered or mailed.

          14. Severability. Whenever possible, each provision of this Agreement shall be
interpreted in such manner as to be effective and valid under applicable law, but if any provision
of this Agreement is held to be invalid, illegal or unenforceable in any respect under any
applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall
not affect any other provision or any other jurisdiction, but this Agreement shall be reformed,
construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision
had never been contained herein.

          15. Complete Agreement. This Agreement, those documents expressly referred to herein
and other documents of even date herewith embody the complete agreement and understanding among the
parties and supersede and preempt any prior understandings, agreements or representations by or
among the parties, written or oral, which may have related to the subject matter hereof in any way.

          16. No Strict Construction. The language used in this Agreement shall be deemed to be
the language chosen by the parties hereto to express their mutual intent, and no rule of strict
construction shall be applied against any party.

          17. Counterparts. This Agreement may be executed in separate counterparts, each of
which is deemed to be an original and all of which taken together constitute one and the same
agreement.

          18. Successors and Assigns. This Agreement is intended to bind and inure to the
benefit of and be enforceable by Employee, the Company and their respective heirs, successors and
assigns, except that Employee may not assign his or her rights or delegate his or her obligations
hereunder without the prior written consent of the Company.

          19. Choice of Law; Consent to Jurisdiction. All issues and questions concerning the
construction, validity, enforcement and interpretation of this Agreement and the exhibits and
schedules hereto shall be governed by, and construed in accordance with, the laws of the
Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict of law rules
or provisions (whether of the Commonwealth of Pennsylvania or any other jurisdiction) that would
cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania.
In the case of any dispute under or in connection with this Agreement, the Employee may only bring
suit against the Company in the Courts of the State of Pennsylvania in and for the County of
Montgomery or in the Federal District Court for such geographic location. The Employee hereby
consents to the jurisdiction and venue of the courts of the State of Pennsylvania in and for the
County of Montgomery or the Federal District Court for such geographic location, provided that such
Federal Court has subject matter jurisdiction over such dispute, and the Employee hereby waives any
claim he or she may have at any time as to forum non conveniens with respect to such venue. The
Company shall have the right to institute any legal action arising out of or relating to this
Agreement in any appropriate court and

-6-

 

in any jurisdiction. Any judgment entered against either of the parties in any proceeding
hereunder may be entered and enforced by any court of competent jurisdiction.

          20. Amendment and Waiver. The provisions of this Agreement may be amended or waived
only with the prior written consent of the Company and Employee, and no course of conduct or
failure or delay in enforcing the provisions of this Agreement shall affect the validity, binding
effect or enforceability of this Agreement.

* * * * *

-7-

 

          IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the date
first written above.

	 	 	 	 	 
	 	RESEARCH PHARMACEUTICAL SEARCH, INC.

 	 
	 	By:  	/s/ Daniel M. Perlman
 	 
	 	 	Its: President 	 
	 
	 	/s/ Janet L. Brennan
 	 
	 	Employeeexv10w10

Exhibit 10.10

RESEARCH PHARMACEUTICAL SERVICES, INC.

2007 EQUITY INCENTIVE PLAN

AWARD AGREEMENT

     Research Pharmaceutical Services, Inc., a Delaware corporation (the “Company”), hereby grants
to _________ (the “Optionee”), an employee of the Company or a related entity, a nonqualified stock
option (the “Option”) to purchase _________ shares (the “Option Shares”) of the Company’s common
stock on _________ (the “Grant Date”). Except as otherwise specified herein or unless the
context requires otherwise, the terms defined in the Research Pharmaceutical Services, Inc. 2007
Equity Incentive Plan (the “Plan”) will have the same meanings herein.

     NOW, THEREFORE, in consideration of these premises and the agreements set forth herein, the
parties hereto agree as follows:

          1. Nature of the Option. This Option is a nonqualified stock option.

          2. Term of Option. This Option may not be exercised later than the date that is ten (10)
years after the Grant Date, subject to earlier termination or cancellation, as provided in the Plan
or Section 6 hereof.

          3. Option Exercise Price. The cost to the Optionee to purchase, pursuant to this Award
Agreement, one Share is $______.

          4. Exercise of Option. This Option will be exercisable during its term only in accordance
with the terms and provisions of the Plan and this Award Agreement, as follows:

               (a) Right to Exercise.

                    (i) The Option shall become exercisable with respect to thirty-three and one-third percent
(331/3 percent) of the Option Shares on _________, provided the Optionee has not incurred a
Termination of Service as of the applicable vesting date; and

                    (ii) Thereafter, the Option shall become exercisable with respect to an additional eight and
one-third percent (81/3 percent) of the Option Shares at the end of each consecutive ninety (90) day
period following _________, provided the Optionee has not incurred a Termination of Service as of
the applicable vesting date.

                    (iii) Notwithstanding paragraphs (i) and (ii) above, this Option may not be exercised from the
effective time of a Form 10 (General Form for Registration of Securities) (if any) that is filed
with the Securities and Exchange Commission (the “SEC”) until the time the underlying Option Shares
have been registered with the SEC by means of a Form S-8 (Registration Statement Under the
Securities Act of 1933) duly filed with the SEC.

               (b) Method of Exercise. The Optionee may exercise this Option by providing written notice
stating the election to exercise this Option. Such written notice must be signed by the Optionee
and must be delivered in person or by certified mail to the Secretary of

 

the Company or such other person as may be designated by the Company. The written notice must
be accompanied by (i) payment of the option exercise price in the manner described in Section 4(c)
hereof, and (ii) any other agreements required by the Board or its Committee and/or the terms of
the Plan, which other agreements may restrict the sale or other transfer of the Option Shares and
may include certain additional representations and agreements as to the Optionee’s investment
intent with respect to the Option Shares. This Option will be deemed to be exercised only upon the
receipt by the Company of such written notice, payment of the option exercise price, and any other
agreements required by the Board or its Committee, the terms of the Plan and/or this Award
Agreement. The Optionee will have no right to vote or receive dividends and will have no other
rights as a stockholder with respect to such Option Shares notwithstanding the exercise of this
Option, until the issuance (as evidenced by the appropriate entry on the books of the Company or of
a duly authorized transfer agent of the Company) of the stock certificate(s) evidencing those
Shares that are being issued upon exercise of this Option. The certificate(s) for the Option
Shares will be registered in the name of the Optionee and will contain any legend as may be
required under the Plan, this Award Agreement, and/or applicable law.

               (c) Method of Payment. The method of payment of the option exercise price may consist
entirely of cash or personal or certified check, or such other consideration or method of payment
as may be authorized under the Plan, in addition to or in place of cash or check, as may be
determined by the Board or its Committee at the time of exercise.

               (d) Partial Exercise. This Option may be exercised in whole or in part; provided, however,
that any exercise may apply only with respect to a whole number of Option Shares.

               (e) Restrictions on Exercise. This Option may not be exercised if the issuance of Option
Shares upon such exercise would constitute a violation of any applicable federal or state
securities laws or other laws or regulations. In addition, as a further condition to the exercise
of this Option, the Company may require the Optionee to make any representation or warranty to the
Company as may be required by or advisable under any applicable law or regulation.

          5. Investment Representations. Unless the Option Shares have been registered under the
Securities Act, in connection with the acquisition of this Option, the Optionee represents and
warrants to the Company as follows:

               (a) The Optionee is acquiring this Option, and upon exercise of this Option, the Optionee will
be acquiring the Option Shares for investment for his own account, not as a nominee or agent, and
not with a view to or for resale in connection with any distribution thereof.

               (b) The Optionee has a preexisting business or personal relationship with the Company or its
affiliates or one of its directors, officers or controlling persons and by reason of his business
or financial experience, has, and could be reasonably assumed to have, the capacity to protect his
interests in connection with the acquisition of this Option and the Option Shares.

-2-

 

          6. Termination of Service.

               (a) Generally. Except as provided in Section 4(a)(iii) hereof, if the Optionee incurs a
Termination of Service for any reason other than death, Disability or termination for Cause, this
Option (to the extent exercisable at the time of such termination) may be exercised at any time
within three (3) months after the date of such termination. To the extent that this Option is not
exercisable at the time of such termination, or to the extent this Option is not exercised within
the time specified herein, this Option will terminate.

               (b) Disability. If the Optionee incurs a Termination of Service due to Disability, this
Option (to the extent exercisable at the time of such termination) may be exercised by the Optionee
or his legal guardian or representative at any time within twelve (12) months after such
termination. To the extent that this Option is not exercisable on the date of Termination of
Service, or to the extent this Option is not exercised within the time specified herein, this
Option will terminate.

               (c) Death. If the Optionee incurs a Termination of Service due to his death, this Option (to
the extent exercisable at the time of such death) will remain exercisable for twelve (12) months
after the date of death by the Optionee’s estate or by a person who acquired the right to exercise
this Option by bequest or inheritance. To the extent that this Option is not exercisable on the
date of death, or to the extent this Option is not exercised within the time specified herein, this
Option will terminate.

               (d) Cause. If the Optionee incurs a Termination of Service for Cause, this Option will be
immediately and automatically canceled and the Optionee will have no further rights therein.

Notwithstanding any other provision of this Section 6, this Option will not be exercisable after
the expiration of the term set forth in Section 2 hereof.

          7. Non-Transferability of Option. This Option may not be sold, pledged, assigned,
hypothecated, gifted, transferred or disposed of in any manner either voluntarily or involuntarily
by operation of law, other than by will or by the laws of descent or distribution. During the
Optionee’s lifetime, this Option is exercisable only by the Optionee. Subject to the foregoing and
the terms of the Plan, the terms of this Option will be binding upon the executors, administrators
and heirs of the Optionee.

          8. No Continuation of Employment. Neither the Plan nor this Option will confer upon the
Optionee any right to continue in the service of the Company or its affiliates or limit, in any
respect, the right of the Company or its affiliates to discharge the Optionee at any time, with or
without Cause and with or without notice.

          9. Market Stand-Off. The Optionee agrees that, in connection with any public offering by the
Company of its equity securities pursuant to a registration statement filed under the Securities
Act, not to sell, make any short sale of, loan, hypothecate, pledge, grant any option for the
purchase of or otherwise dispose of any Option Shares without the prior written consent of the
Company or its underwriters, for such period of time from the effective date of such registration
as may be requested by the Company or such underwriters.

-3-

 

          10. Withholding. The Company reserves the right to withhold, in accordance with any
applicable laws, from any consideration payable or property transferable to the Optionee any taxes
required to be withheld by federal, state or local law as a result of the grant or exercise of this
Option or the sale or other disposition of the Option Shares. If the amount of any consideration
payable to the Optionee is insufficient to pay such taxes or if no consideration is payable to the
Optionee, upon the request of the Company, the Optionee (or such other person entitled to exercise
this Option pursuant to Section 6 hereof) will pay to the Company an amount sufficient for the
Company to satisfy any federal, state or local tax withholding requirements applicable to the grant
or exercise of this Option or the sale or other disposition of the Option Shares.

          11. Entire Agreement. This Award Agreement, together with the Plan and the other exhibits
attached thereto or hereto, represents the entire agreement between the parties hereto relating to
the subject matter hereof, and merges and supersedes all prior and contemporaneous discussions,
agreements and understandings of every nature relating to the award of Options to Optionee by the
Company (other than any written Award Agreement executed in connection with another award of
Options to Optionee). This Award Agreement may not be changed or modified, except by an agreement
in writing signed by each of the parties hereto.

          12. Governing Law. This Award Agreement will be construed in accordance with the laws of the
state of Delaware, without regard to the application of the principles of conflicts of laws.

          13. Amendment. Subject to the provisions of the Plan, this Award Agreement may only be
amended by a writing signed by each of the parties hereto.

          14. The Plan. The Optionee has received a copy of the Plan (a copy of which is attached
hereto), has read the Plan and is familiar with its terms, and hereby accepts the Option subject to
all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan,
the Board or its Committee is authorized to interpret the Plan and to adopt rules and regulations
not inconsistent with the Plan as it deems appropriate. The Optionee hereby agrees to accept as
binding, conclusive and final all decisions or interpretations of the Board or its Committee upon
any questions arising under the Plan.

[Signature page follows]

-4-

 

     IN WITNESS WHEREOF and intending to be legally bound hereby, this Award Agreement is hereby
executed.

	 	 	 	 	 	 
	 	RESEARCH PHARMACEUTICAL SERVICES, INC.

 	 
	 	By:  	
 	 
	 	 	Title: 	 
	 	 	 	 
	 

     The Optionee acknowledges receipt of a copy of the Plan, a copy of which is attached hereto,
and represents that he or she has read and is familiar with the terms and provisions thereof and
hereby accepts this Option subject to all of the terms and provisions of the Award Agreement and
the Plan. The Optionee hereby agrees to accept as binding, conclusive and final all decisions or
interpretations of the Board or the Committee upon any questions arising under the Plan.

	 	 	 	 	 
	 	OPTIONEE

__________________________________________

Signature, Date:

Address: ___________________________________
 	 
	 	 	 
	 	 	 
	 	 	 
	 

THIS OPTION AND THE SECURITIES WHICH MAY BE PURCHASED UPON EXERCISE OF THIS OPTION HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS.
THESE SECURITIES MAY NOT BE ACQUIRED WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE SOLD,
ASSIGNED, EXCHANGED, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR DISPOSED OF, BY
GIFT OR OTHERWISE, OR IN ANY WAY ENCUMBERED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH
SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS,
OR A SATISFACTORY OPINION OF COUNSEL SATISFACTORY TO RESEARCH PHARMACEUTICAL SERVICES, INC. THAT
REGISTRATION IS NOT REQUIRED UNDER SUCH ACT AND UNDER APPLICABLE STATE SECURITIES LAWS.

-5-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}]]